
‘Unparalleled’ study finds psilocybin protects against nerve damage from chemotherapy
The findings, which were made in mice, may offer a new way to prevent a common chemotherapy side effect that can last well beyond treatment

‘Unparalleled’ study finds psilocybin protects against nerve damage from chemotherapy
The findings, which were made in mice, may offer a new way to prevent a common chemotherapy side effect that can last well beyond treatment

Researchers test magic mushrooms as an anorexia treatment
Researchers are exploring whether magic mushrooms could offer a new treatment for anorexia


How psilocybin alters consciousness to create a sense of ‘oneness’
Psychedelics can create a new “hidden order” in brain activity that could explain how these drugs alter our sense of self

New psychedelic clinics treat rare post-trip harms
As psychedelic therapies expand, new clinics treat uncommon long-term harms

Can ‘magic mushrooms’ help treat cocaine dependence?
Psychedelic-assisted therapy could open a new path for treating cocaine use disorder, which has no approved medications yet

Could psilocybin be the key to treating anorexia?
An active ingredient in magic mushrooms, psilocybin has shown early promise for treating eating disorders

Trump’s psychedelics executive order could accelerate new treatments—including for children
The Trump administration has fast-tracked research into psychedelics, and experts say it is likely a matter of time before the drugs are used to treat minors

Americans are increasingly open to using psychedelics for medical reasons
A survey found that more than 60 percent of respondents “strongly support” making psychedelics easier to study, reflecting a growing consensus that some could have therapeutic use

Does a psychedelic trip change your brain? A new study offers a tantalizing clue
Scientists gave people a “heroic” dose of psilocybin and then looked at their brain. Here’s what happened

Inside the ibogaine rush: How psychedelic therapy is going mainstream
Tracing how psychedelics have undergone a revival in the U.S. and what the White House’s new psychedelic push means for research

RFK, Jr., says ibogaine holds unprecedented promise for treating depression. Here’s what the science says
At a Senate hearing on Wednesday, Robert F. Kennedy, Jr., referred to ibogaine as the most promising treatment for PTSD and depression “that anybody’s ever seen.” Does the science hold that up?

Where did magic mushrooms come from? Scientists just got closer to an answer
Scientists just discovered a new species of magic mushroom, Psilocybe ochraceocentrata, that appears to have shared a common ancestor with the popular Psilocybe cubensis some 1.5 million years ago